Indirect recognition of t-cell epitopes derived from the α3 and transmembrane domain of HLA-A2

被引:17
作者
Hanvesakul, R.
Maillere, B.
Briggs, D.
Baker, R.
Larche, M.
Ball, S. [1 ]
机构
[1] Univ Hosp Birmingham, Dept Renal Med, Birmingham, W Midlands, England
[2] Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England
[3] CEA, Dept Ingn & Etud Prot, Saclay, France
[4] Natl Blood Serv, H&I Lab, Birmingham, W Midlands, England
[5] St James Hosp, Dept Renal Med, Leeds, W Yorkshire, England
[6] Univ London Imperial Coll Sci & Technol, Natl Heart & Lung Inst, London, England
关键词
alloantibody; allorecognition; epitope; peptide;
D O I
10.1111/j.1600-6143.2007.01743.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Indirect allorecognition has been implicated in the mechanism of chronic rejection and alloantibody formation but precise definition of the epitopes involved has been limited. We have undertaken a detailed assessment of the antigenic properties of peptides derived from HLA-A2. Candidate epitopes were identified in vitro by assessment of MHC class II binding. The immune response to these epitopes was determined in patients awaiting a renal transplant by the assessment of PBMC activation using gamma-interferon ELISPOT. Twenty-two of fifty-five patients responded to peptides from HLA-A2 and this was associated with but not confined to those who had made antibody to HLA-A2 (14/18). Nineteen of twenty-two patients responded to peptides derived from the hypervariable alpha 1 and alpha 2 domains and 18/22 responded to peptides from the alpha 3 and transmembrane domain, the sequences of which show little polymorphism. In six patients, the sequence of these peptides was identical to self, that is, the response was autoimmune. The finding of indirect epitopes derived from regions of MHC class I that exhibit little polymorphism provides a novel perspective on the immune response to alloantigen and has potential implications for the development of specific therapies.
引用
收藏
页码:1148 / 1157
页数:10
相关论文
共 52 条
  • [21] Magee CC, 1999, J AM SOC NEPHROL, V10, P1997
  • [22] Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes - A paired donor kidney analysis
    Meier-Kriesche, HU
    Kaplan, B
    [J]. TRANSPLANTATION, 2002, 74 (10) : 1377 - 1381
  • [23] Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: An efficient way to induce indirect pathway regulation
    Mirenda, V
    Berton, I
    Read, J
    Cook, T
    Smith, J
    Dorling, A
    Lechler, RI
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (04): : 987 - 997
  • [24] Najafian N, 2002, J AM SOC NEPHROL, V13, P252, DOI 10.1681/ASN.V131252
  • [25] NISCO S, 1994, J IMMUNOL, V152, P3786
  • [26] Pettigrew GJ, 1998, J IMMUNOL, V161, P1292
  • [27] Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome
    Reznik, SI
    Jaramillo, A
    SivaSai, KSR
    Womer, KL
    Sayegh, MH
    Trulock, EP
    Patterson, GA
    Mohanakumar, T
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (03) : 228 - 235
  • [28] Pretransplant blood transfusions revisited:: A role for CD4+ regulatory T cells?
    Roelen, D
    Brand, A
    Claas, FHJ
    [J]. TRANSPLANTATION, 2004, 77 (01) : S26 - S28
  • [29] Allorecognition
    Rogers, NJ
    Lechler, RI
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (02) : 97 - 102
  • [30] Alloantibody production is regulated by CD4+ T cells' alloreactive pathway, rather than precursor frequency or Th1/Th2 differentiation
    Sauvé, D
    Baratin, M
    Leduc, C
    Bonin, K
    Daniel, C
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (08) : 1237 - 1245